featured
Regorafenib vs Placebo in Patients With Previously Treated Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Regorafenib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Asian Patients With Previously Treated Metastatic Colorectal Cancer (CONCUR): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Oncol 2015 May 13;[EPub Ahead of Print], J Li, S Qin, R Xu, TC Yau, B Ma, H Pan, J Xu, Y Bai, Y Chi, L Wang, KH Yeh, F Bi, Y Cheng, AT Le, JK Lin, T Liu, D Ma, C Kappeler, J Kalmus, TW KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.